Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. (NY: SNY )

43.41 USD UNCHANGED
Last Price Updated: 5:16 PM EST, Dec 31, 2018 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Sanofi-Aventis S.A.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Where Will Vaxart Be in 1 Year?
The coronavirus vaccine stock's roller-coaster ride will continue. 
Tags MRNA SNY VXRT
From Motley Fool
These 5 Healthcare Stocks Are the Biggest Winners in 2020
It's not a surprise that all five of these stocks are engaged in the fight against the novel coronavirus. 
Tags LH OPK NVAX
From Motley Fool
These 5 Stocks Are The Biggest S&P 500 Healthcare Winners of 2020
Some of the names on this list may surprise you. 
Tags IDXX WST SNY
From Motley Fool
3 Stocks to Buy Ahead of the Next Market Crash
These companies are all trading at cheap multiples relative to their earnings. 
Tags KO GSK Market News
From Motley Fool
5 Sectors Set to Boom on Coronavirus Vaccine Optimism: Top Picks
Wall Street has been on a stellar ride since hitting its bottom in late March. 
Tags Stocks / Equities Services Capital & Industrial Goods
From Blogs - TalkMarkets
Vaxart Stock: Should You Buy the Dip?
Shares of this company, which is making a COVID-19 vaccine in pill form, sell for less than half their peak. 
Tags NVAX MRNA SNY
From Motley Fool
Got $1,000? These Dirt-Cheap Stocks Are Practically Free
These rough and tumble coronavirus stocks could help fund your retirement. 
Tags PFE SNY PRNB
From Motley Fool
A Look Into Healthcare Sector Value Stocks
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that ... 
Tags Biotechnology Benzinga Dividends
From Benzinga
CureVac and EU in advanced talks for 225 million Covid-19 vaccine doses
Shares of CureVac NV soared Thursday after the German biotech firm said it was in advanced talks for the supply of at least 225 million doses of a potential Covid-19 vaccine to EU member states. 
Tags Medical Products UK:GSK JNJ
From MarketWatch
Hot Biotech IPO Latest To Gain In Coronavirus Vaccine Race
Tiny CureVac, which popped in its IPO on Friday, announced Thursday it's close to inking a big contract with the European Commission for its coronavirus vaccine candidate. CVAC stock jumped. 
From Investor's Business Daily
Johnson & Johnson To Acquire Momenta Pharmaceuticals For $6.5 Billion
Johnson & Johnson will buy Momenta Pharmaceuticals for $6.5 billion to broaden its reach in treating autoimmune and rare diseases. 
From Investor's Business Daily
The Daily Biotech Pulse: Poseida's Phase 1 Study Placed On Clinical Hold, Orphan Drug Designation For Krystal Biotech, Tiziana's Patent Award
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) Catalent Inc (NYSE: CTLT) CureVac N.V. (NASDAQ: CVAC) ... 
Tags QGEN INZY Trading Ideas
From Benzinga
(PRNB) Alert: Johnson Fistel Investigates Proposed Sale of Principia Biopharma; Are Shareholders Getting a Fair Price?
From GlobeNewswire News Releases
Sanofi Acquiring Principia Biopharma for $3.7 Billion
This isn't the pharmaceutical giant's only recent ride at the acquisition rodeo. 
Tags Market News PRNB SNY
From Motley Fool
PRINCIPIA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRNB and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Principia Biopharma Inc. (NASDAQ: PRNB) breached their... 
From Business Wire News Releases
PRINCIPIA BIOPHARMA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
From GlobeNewswire News Releases
Sanofi To Purchase Immune System-Focused Drugmaker Principia Biopharma For $3.7B
Sanofi SA will acquire Principia Biopharma Inc for $3.68 billion in cash, the two companies announced Monday. 
Tags Pharma/Biotech Healthcare Stocks / Equities
From Blogs - TalkMarkets
Sanofi To Acquire Partner Principia Biopharma, Expand MS Treatment Efforts
Sanofi is expanding efforts to combat MS and other autoimmune diseases by announcing a $3.68 billion acquisition of partner Principia Biopharma. 
From Investor's Business Daily
(PRNB) Alert: Johnson Fistel Investigates Proposed Sale of Principia Biopharma; Is $100 a Fair Price?
Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Principia Biopharma Inc. ("Principia " or the "Company") (NASDAQ: PRNB) breached their... 
From PR Newswire
A Look Into Sanofi's Debt
Over the past three months, shares of Sanofi Inc. (NASDAQ: SNY) increased by 7.48%. Before having a look at the importance of debt, ... 
Tags News Market News Debt Insights
From Benzinga
Sanofi Acquires Principia Biopharma For $100 Per Share Or $3.68B
Sanofi and Principia Biopharma entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash, which represents an aggregate... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
A Peek Into The Markets: US Stock Futures Rise Following Prior Week's Gains
Pre-open movers U.S. stock futures traded higher in early pre-market trade, after recording gains in the previous week. The Empire ... 
Tags Pre/Market Outlook Market News CASBF
From Benzinga
Sanofi To Purchase Immune System-Focused Drugmaker Principia Biopharma For $3.7B
Sanofi SA (NASDAQ: SNY) will acquire Principia Biopharma Inc (NASDAQ: PRNB) for $3.68 billion in cash, the two companies announced ... 
Tags M&A Market News Benzinga
From Benzinga
Sanofi to acquire Principia Biopharma
* Further strengthens core R&D areas of autoimmune and allergic diseases 
From PR Newswire
2 Top Pharma Stocks to Buy in August
Here's why these recession-proof stocks are great buy-and-hold opportunities for the long term. 
Tags REGN SNY Market News
From Motley Fool
Better Coronavirus Stock: AstraZeneca vs. Regeneron
Both companies are leaders in the fight against COVID-19. But one appears to have a clear advantage. 
Tags AZN Market News REGN
From Motley Fool
Novavax To Supply 60M Coronavirus Vaccine Doses To UK Under New Deal
Novavax, Inc announced Friday it has reached terms with the government of the United Kingdom to supply 60 million doses of its COVID-19 vaccine, subject to success of pending clinical trials. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Novavax To Supply 60M Coronavirus Vaccine Doses To UK Under New Deal
Novavax, Inc (NASDAQ: NVAX) announced Friday it has reached terms with the government of the United Kingdom to supply60 million ... 
Tags Coronavirus Vaccine Global MRNA
From Benzinga
Why in the World Is Novavax Stock Up 4,000%?
The small-cap biotech has emerged as one of the favorites in the race for a COVID-19 vaccine. 
Tags Market News NVAX SNY
From Motley Fool
Novavax Cuts Losses In Second Quarter, Sales Beat Views; NVAX Stock Edges Up
Coronavirus vaccine maker Novavax reported quarterly results that beat on the top and bottom lines, but NVAX stock fell late after touching a five-year closing high in the regular session. 
From Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback